Oxygen turns out to be the switch that explains why humans can’t regrow limbs
Some animals simply grow a new leg when the old one is gone. Humans don’t. Scientists have known for decades that a fundamental difference must exist between species that can regenerate and…
Limb regeneration is one of the most striking abilities in the animal kingdom. Mexican water salamanders do it effortlessly. Certain species of frogs and fish can too. But land-dwelling vertebrates that breathe higher concentrations of oxygen — birds and mammals — have largely lost that capacity over evolutionary time. Why exactly has been a persistent puzzle.
A new study in Science offers a surprising answer: it comes down to oxygen sensing. Salamanders living in water inhabit an environment with relatively low oxygen tension. When a limb is severed, a molecular sensor, a protein called HIF-1α, detects a local drop in oxygen at the wound site. That signal activates a cascade of genes that trigger cell division, tissue formation, and ultimately full regeneration. The wound is essentially read as an oxygen deficiency alarm. This alarm starts the repair engine.
How species determine whether the alarm fires
In mammals, the same HIF-1α system exists, but it’s calibrated differently. The baseline oxygen levels at which mammals live are high enough that the sensor doesn’t easily reach alarm threshold when a wound occurs. The researchers tested this experimentally: by housing axolotls in environments with elevated oxygen concentrations, they measurably weakened the animals’ regenerative capacity. Conversely, by artificially activating the HIF-1α pathway in frog species that normally cannot regenerate, they triggered a modest regenerative program. The capacity was present. The alarm was simply turned off.
This has direct implications for whether regeneration could ever be induced in humans. The study suggests it isn’t about a lost gene or an irreversible evolutionary trade-off, but about a threshold: the oxygen threshold at which the regeneration signal is released. If that threshold could be lowered pharmacologically or genetically, it might theoretically be possible to activate tissue or limb regeneration in an organism that doesn’t normally do it.
From salamander to patient: a vast distance
The gap between this mechanistic insight and human application is enormous. Limb and tissue regeneration isn’t a matter of flipping a switch: it requires coordinated activity across hundreds of genes, the right cell types in the right locations, and an immune environment that facilitates rather than shuts down the process. In humans, serious wounds rapidly trigger scar formation — an evolutionarily advantageous rapid closure that prevents infection but blocks regeneration.
Even so, the study represents genuine scientific progress. It shifts the framing from ‘humans simply can’t do this’ to ‘humans don’t flip the switch.’ That is a fundamentally different question and one that can be pursued with further research. This discovery opens a research avenue with connections to wound healing, organ damage following heart attacks. And the longer-term ambitions of regenerative medicine. Whether those ambitions will ever be realized in a clinical setting remains an open question.